H&Q Healthcare Investors provides early and later stage funding and is a Massachusetts-based healthcare fund.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Apr 3, 2014
Neurovance
|
Series A | $6.30M | Biotechnology | — |
Mar 1, 2013
CardioKinetix
|
Series E | $23M | Biotechnology | — |
Jan 8, 2013
Labcyte
|
Series D | $5.30M | Alternative Medicine | — |
Oct 18, 2012
Neurovance
|
Series Unknown | $7M | Biotechnology | — |
Oct 5, 2011
Puma Biotechnology
|
Post-IPO Equity | $55M | Biotechnology | — |
H&Q Healthcare Investors has had 6 exits. H&Q Healthcare Investors most notable exits include Labcyte , Neurovance
Date | Company Name | Exit Type | Industry | |
---|---|---|---|---|
Jan 30, 2019 | Labcyte | M&A | Alternative Medicine | Detail |
Mar 2, 2017 | Neurovance | M&A | Biotechnology | Detail |
May 11, 2015 | PHT Corporation | M&A | Clinical Trials | Detail |
Apr 20, 2012 | Puma Biotechnology | IPO | Biotechnology | Detail |
Mar 19, 2008 | CardioNet | IPO | Biotechnology | Detail |